BeStock  
Stocks › Biotechnology › AGIO

Agios Pharmaceuticals AGIO

US equityMarket cap rank #2826Biotechnology
$31.25 −$0.55 (-1.73%)
Pre-market · Oct 6, 4:10 am ET · After hours $31.25 0.00%
Open$31.65
Prev close$31.80
Day range$30.78 – $31.76
Volume808.7K
Market cap$1.87B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$54.03M+48.0% YoY
Operating profit-$472.13M-10.9% YoY
Net profit-$412.78M-161.3% YoY
Diluted EPS-$7.12-161.2% YoY

Annual revenue

$0.0FY20$0.0FY21$14.2MFY22$26.8MFY23$36.5MFY24$54.0MFY25

Profitability & balance sheet

Gross margin88.3%
Operating margin-873.9%
Net margin-764.0%
Liabilities / assets8.0%
Cash & investments$854.43M
Total debt$21.82M
Net cash (debt)$832.61M

Income statement

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Diluted EPS -$7.12 $11.64 -$6.33 -$4.23 $26.55
Operating Expense $519.82M $458.07M $415.43M $401.58M $378.42M
Gross Profit $47.68M $32.33M $23.94M $12.54M $0.00
Cost of Revenue $6.35M $4.17M $2.88M $1.70M $0.00
Total Operating Revenue $54.03M $36.50M $26.82M $14.24M $0.00
Total Revenue as Reported $54.03M $36.50M $26.82M $14.24M $0.00
Net Profit -$412.78M $673.73M -$352.09M -$231.80M $1.60B
Selling and Admin Expenses $180.28M $156.78M $119.90M $121.67M $121.45M
Research & Development $339.54M $301.29M $295.53M $279.91M $256.97M
Basic EPS -$7.12 $11.86 -$6.33 -$4.23 $26.55
Net Income to Common Stockholders -$412.78M $673.73M -$352.09M -$231.80M $1.60B
Net Income to Parent Company -$412.78M $673.73M -$352.09M -$231.80M $1.60B
Profit from Continuing Operations -$412.78M $673.73M -$352.09M -$231.80M -$356.51M
Tax -$1.02M $44.24M $0.00 $0.00 –
Pretax Profit -$413.80M $717.97M -$352.09M -$231.80M -$356.51M
Other Non-Operating Income (Expenses) $1.96M $6.49M $6.06M $6.75M $14.43M
-Gain on Sale Of Business $0.00 $1.09B $0.00 $137.70M $6.64M
Special Income (Charges) $0.00 $1.09B $0.00 $137.70M $6.64M
Other Income (Expense) $1.96M $1.10B $6.06M $144.45M $21.07M
Non-Operating Interest Income $56.38M $48.08M $33.34M $12.79M $836,000.00
Net Non-Operating Interest Income (Expense) $56.38M $48.08M $33.34M $12.79M $836,000.00
Operating Profit -$472.13M -$425.74M -$391.49M -$389.05M -$378.42M
Net Income from Discontinuous Operations – – – – $1.96B

Balance sheet

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Total Assets $1.30B $1.66B $937.12M $1.24B $1.44B
Total Current Assets $942.05M $965.60M $833.84M $832.77M $1.06B
Cash and Cash Equivalents & Short-Term Investments $854.43M $893.71M $776.93M $783.12M $1.02B
-Cash and Cash Equivalents $89.13M $76.25M $88.21M $139.26M $203.13M
-Short Term Investments $765.30M $817.46M $688.72M $643.86M $816.89M
Receivables $10.58M $4.11M $2.81M $2.21M $4.38M
-Accounts Receivable $10.58M $4.11M $2.81M $2.21M $0.00
Inventory $32.92M $27.62M $19.08M $8.49M $0.00
Payables $18.36M $17.51M $9.78M $18.62M $16.70M
-Long Term Capital Lease Obligation $21.82M $40.21M $56.99M $72.00M $85.94M
Long Term Debt and Capital Lease Obligation $21.82M $40.21M $56.99M $72.00M $85.94M
Total Non-Current Liabilities $21.91M $41.09M $58.14M $75.28M $85.94M
Short-Term Debt and Capital Lease Obligation $18.39M $16.78M $15.01M $13.66M $11.16M
Current Accrued Expenses $18.20M $16.93M $19.94M $12.25M $12.15M
-Total Tax Payable $0.00 $871,000.00 $0.00 – –
-Accounts Payable $18.36M $16.64M $9.78M $18.62M $16.70M
Total Current Liabilities $82.21M $81.16M $67.96M $62.63M $59.83M
Other Non-Current Liabilities $90,000.00 $880,000.00 $1.16M $3.28M –
Total Equity $1.19B $1.54B $811.02M $1.10B $1.29B
Gains/Losses Not Affecting Retained Earnings $2.19M -$1.52M -$441,000.00 -$12.54M -$1.20M
Less: Treasury Stock $802.49M $802.49M $802.49M $802.49M $802.49M
Retained Earnings -$561.71M -$148.92M -$822.65M -$470.56M -$238.76M
Additional Paid-In Capital $2.56B $2.49B $2.44B $2.39B $2.33B
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $75,000.00 $73,000.00 $72,000.00 $71,000.00 $71,000.00
Capital Stock $75,000.00 $73,000.00 $72,000.00 $71,000.00 $71,000.00
Stockholders' Equity $1.19B $1.54B $811.02M $1.10B $1.29B
-Current Capital Lease Obligation $18.39M $16.78M $15.01M $13.66M $11.16M
-Accumulated Depreciation -$60.12M -$56.50M -$52.23M -$50.07M -$44.97M
-Available for Sale Securities $310.01M $638.32M $29.44M $313.87M $266.38M
-Gross PPE $101.34M $111.05M $122.02M $138.19M $149.20M
Net PPE $41.23M $54.55M $69.79M $88.12M $104.23M
Total Non-Current Assets $355.17M $697.60M $103.28M $405.95M $373.51M
Other Current Assets $44.13M $40.17M $35.02M $38.96M $39.84M
Other Non-Current Assets $3.93M $4.72M $4.06M $3.96M $2.90M
Total Liabilities $104.11M $122.24M $126.10M $137.90M $145.76M
Investments and Advances $310.01M $638.32M $29.44M $313.87M $266.38M
-Other Receivables – – – – $4.38M

Discussion

No comments yet — be the first to weigh in on AGIO.

Leave a comment

Scroll to Top